RESULTS	A total of 221 of 327 patients completed the SB phase , 194 ( 96 in the gabapentin enacarbil group and 98 in the placebo group ) were randomized to DB treatment , and 168 ( 84 in the gabapentin enacarbil group and 84 in the placebo group ) completed the DB phase .\